In vivo biocompatibility of Resilon compared with gutta-percha in a pre-clinical model
Abstract
Background: The aim of this study was to investigate in vivo biocompatibility of Resilon, compared with
gutta-percha, at short and long-term following implantation in a rat subcutaneous implantation model.
Materials and Methods: Male Wistar rats were implanted subcutaneously with either Resilon
or gutta-percha or were sham controls. Tissues were harvested at 8 days or 60 days after
implantation and were evaluated histologically for inflammation and fibrous encapsulation. The
severity of histologic injury, scored on a scale of 0-4 and quantitative analysis of the capsule wall
thickness were determined for statistical analysis. Data were analyzed by Student t-test, one-way
analysis of variance, Kruskal-Wallis or Mann-Whitney’s tests as appropriate. A value of P ≤ 0.05
was considered statistically significant.
Results: No behavioral changes or visible signs of physical impairment were observed at 8 days
or 60 days post-implantation. Histopathologic observation of the implanted sites at each timepoint
showed that both Resilon and gutta-percha implants induced foreign body reaction, showing
minimal to mild inflammatory reactions in most cases, which diminished significantly with time.
Compared with gutta-percha, the capsule wall was thinner (P > 0.05) after Resilon implantation
at day 8 and significantly (P = 0.01) thicker at day 60. In addition, capsule wall thickness showed
a trend to increase with time after implantation in the Resilon groups (P > 0.05), opposed to the
significant decrease (P = 0.016) observed after implantation in the gutta-percha groups, suggesting
lesser long-term biocompatibility of Resilon.
Conclusion: Our findings validate Resilon as an in vivo biocompatible material. However, our data
suggest that long-term biocompatibility of Resilon, despite validated, is inferior to that of guttapercha
control.
Key Words: Endodontic materials, gutta-percha, rat, Resilon, subcutaneous implantation
Full Text:
PDFRefbacks
- There are currently no refbacks.